Literature DB >> 9764628

Cardiac dysfunction in twin-twin transfusion syndrome: a prospective, longitudinal study.

L L Simpson1, G R Marx, E A Elkadry, M E D'Alton.   

Abstract

OBJECTIVE: To use serial echocardiography to evaluate prospectively the cardiac dysfunction in twin-twin transfusion syndrome and determine its clinical course and outcome.
METHODS: Twin pregnancies presenting in the second trimester with sonographic evidence of twin-twin transfusion syndrome were managed with therapeutic reduction amniocenteses. Gestational age at diagnosis and delivery, number of amniocenteses performed, volume of amniotic fluid withdrawn, placentation, birth weight, hemoglobin at delivery, and perinatal outcome were recorded. Serial fetal echocardiography was carried out in a single tertiary center. Echocardiographic assessments included cardiac anatomy, chamber size, cardiothoracic ratio, interventricular septal thickness, ventricular systolic function, and the presence and severity of atrioventricular valve regurgitation. Postnatal echocardiograms were obtained on the surviving twins.
RESULTS: Twelve cases of twin-twin transfusion syndrome were evaluated with serial echocardiography. Evidence of cardiac dysfunction was present prenatally in 10 recipient twins. All of the donor twins had normal fetal echocardiographic assessments. The most common abnormalities detected prenatally in recipient twins were decreased ventricular function, tricuspid regurgitation, and cardiac chamber enlargement. A deterioration of cardiac function was observed in seven recipient twins with increasing gestational age. Four of the eight surviving recipient twins had persistent postnatal echocardiographic abnormalities on follow-up examinations after the first 28 days of life.
CONCLUSION: Prenatal cardiac dysfunction is common in recipient twins and can be transient, progressive, or persistent beyond the neonatal period.

Entities:  

Mesh:

Year:  1998        PMID: 9764628     DOI: 10.1016/s0029-7844(98)00220-8

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

Review 1.  Fetal cardiovascular physiology.

Authors:  J Rychik
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

2.  Long term cardiac follow up of severe twin to twin transfusion syndrome after intrauterine laser coagulation.

Authors:  U Herberg; W Gross; P Bartmann; C S Banek; K Hecher; J Breuer
Journal:  Heart       Date:  2005-04-06       Impact factor: 5.994

3.  Initial fetal cardiovascular profile score predicts recipient twin outcome in twin-twin transfusion syndrome.

Authors:  Amy D Shah; William L Border; Timothy M Crombleholme; Erik C Michelfelder
Journal:  J Am Soc Echocardiogr       Date:  2008-06-16       Impact factor: 5.251

Review 4.  Controversies in the identification and management of acute pulmonary hypertension in preterm neonates.

Authors:  Regan E Giesinger; Kiran More; Jodie Odame; Amish Jain; Robert P Jankov; Patrick J McNamara
Journal:  Pediatr Res       Date:  2017-10-04       Impact factor: 3.756

5.  Long term outcome of twin-twin transfusion syndrome.

Authors:  R B Cincotta; P H Gray; G Phythian; Y M Rogers; F Y Chan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-11       Impact factor: 5.747

Review 6.  Evaluation and Management of Fetal Cardiac Function and Heart Failure.

Authors:  Erik Michelfelder; Catherine Allen; Lindsay Urbinelli
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-09

7.  Influence of twin-twin transfusion syndrome on fetal cardiovascular structure and function: prospective case-control study of 136 monochorionic twin pregnancies.

Authors:  A A Karatza; J L Wolfenden; M J O Taylor; L Wee; N M Fisk; H M Gardiner
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

8.  The Fetal Heart in Twin-to-Twin Transfusion Syndrome.

Authors:  Tim Van Mieghem; Liesbeth Lewi; Léonardo Gucciardo; Philip Dekoninck; Dominique Van Schoubroeck; Roland Devlieger; Jan Deprest
Journal:  Int J Pediatr       Date:  2010-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.